Clinical Trial: AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

Brief Summary: To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.

Detailed Summary:
Sponsor: Aggredyne, Inc.

Current Primary Outcome: Platelet Activity Index (PAI) before and after ingestion of aspirin [ Time Frame: 2 - 30 hours post aspirin ingestion ]

PAI is the proprietary reporting unit of the Aggreguide. It is related to the amount of platelet aggregation in the sample of whole blood.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Aggredyne, Inc.

Dates:
Date Received: July 30, 2013
Date Started: April 2013
Date Completion:
Last Updated: August 1, 2013
Last Verified: August 2013